You are viewing the site in preview mode

Skip to main content

Advertisement

Contact Brent A. Hanks

From: Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy

Contact corresponding author